INGR

CNBC's Jim Cramer, host of Mad Money, posted on X on Monday, “Hard to believe the drug stocks are so out of sync with food stocks.

AgTech and food innovation reshape agriculture and nutrition, putting ADM, DAR and BG firmly in focus.

Ingredion beats Q2 estimates as 7% Texture & Healthful Solutions volume growth and FX gains offset Argo issues and higher costs.

Ingredion NYSE: INGR reported second-quarter 2026 results that were in line with its expectations, as continued growth in Texture & Healthful Solutions offset operational and macroeconomic pressures in other parts of the portfolio.

Ingredion Incorporated (INGR) Q2 2026 Earnings Call Transcript

Ingredion (INGR) came out with quarterly earnings of $2.82 per share, beating the Zacks Consensus Estimate of $2.73 per share. This compares to earnings of $2.87 per share a year ago.

Second quarter 2026 reported and adjusted* operating income decreased 31% and 5% compared to the second quarter 2025 Second quarter 2026 reported and adjusted EPS were $1.78 and $2.82, compared with $2.99 and $2.87 in the second quarter 2025 Reaffirming amended full-year guidance, which now reflects the sale of a majority stake in the Pakistan business, for reported EPS to be in the range of $9.15 to $9.75 and adjusted EPS to be in the range of $10.30 to $10.90 Ingredion's 595 pence all-cash offer to acquire Tate & Lyle accepted by their shareholders WESTCHESTER, Ill., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its second quarter 2026 results.

Ingredion's cheap valuation and growing specialty business support the bull case, but Argo execution risks and weaker guidance argue for patience.

Ingredion's proposed $5 billion Tate & Lyle deal could expand its specialty platform and global reach, but approvals and integration risks remain.

Tate & Lyle shareholders accept Ingredion's recommended cash offer Shareholder acceptance marks an important milestone toward creating a global ingredient solutions leader with enhanced innovation and formulation capabilities Closing expected in H2 2027, subject to the satisfaction of regulatory conditions WESTCHESTER, Ill., July 28, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR) (“Ingredion”), a leading global provider of ingredient solutions for food, beverage, pharmaceutical, personal care, and industrial applications, confirms that shareholders of Tate & Lyle PLC (“Tate & Lyle”), a global leader in mouthfeel, sweetening and fortification, have today accepted the terms of a recommended all-cash offer by Ingredion for the entire issued and to be issued share capital of Tate & Lyle, as announced on June 8, 2026.